{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:22:24Z","timestamp":1773282144235,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s13346-020-00871-9","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T19:03:44Z","timestamp":1604948624000},"page":"2096-2107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effect of surfactant concentration and sterilization process on intraocular pressure\u2013lowering activity of \u03949-tetrahydrocannabinol-valine-hemisuccinate (NB1111) nanoemulsions"],"prefix":"10.1007","volume":"11","author":[{"given":"Corinne","family":"Sweeney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narendar","family":"Dudhipala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruchi","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tabish","family":"Mehraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushrut","family":"Marathe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waseem","family":"Gul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud. A.","family":"ElSohly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumyajit","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,9]]},"reference":[{"key":"871_CR1","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311:1901.","journal-title":"JAMA"},{"key":"871_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/tvst.8.5.15","volume":"8","author":"PS Taskar","year":"2019","unstructured":"Taskar PS, Patil A, Lakhani P, Ashour E, Gul W, ElSohly MA, et al. \u03949-Tetrahydrocannabinol derivative-loaded nanoformulation lowers intraocular pressure in normotensive rabbits. Transl Vis Sci Technol. 2019;8:15\u201315.","journal-title":"Transl Vis Sci Technol"},{"key":"871_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mjafi.2015.12.001","volume":"72","author":"JKS Parihar","year":"2016","unstructured":"Parihar JKS. Glaucoma: the \u2018Black hole\u2019 of irreversible blindness. Med J Armed Forces India. 2016;72:3\u20134.","journal-title":"Med J Armed Forces India"},{"key":"871_CR4","doi-asserted-by":"publisher","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","volume":"5","author":"SR Flaxman","year":"2017","unstructured":"Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, et al. Global causes of blindness and distance vision impairment 1990\u20132020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5:e1221\u201334.","journal-title":"Lancet Glob Health"},{"key":"871_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2174\/1874364101004010052","volume":"4","author":"M Goel","year":"2010","unstructured":"Goel M, Picciani RG, Lee RK, Bhattacharya SK. Aqueous humor dynamics: a review. Open Ophthalmol J. 2010;4:52\u20139.","journal-title":"Open Ophthalmol J"},{"key":"871_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejpb.2015.04.029","volume":"95","author":"BM Braunger","year":"2015","unstructured":"Braunger BM, Fuchshofer R, Tamm ER. The aqueous humor outflow pathways in glaucoma: a unifying concept of disease mechanisms and causative treatment. Eur J Pharm Biopharm. 2015;95:173\u201381.","journal-title":"Eur J Pharm Biopharm"},{"key":"871_CR7","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"Y-C Tham","year":"2014","unstructured":"Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology. 2014;121:2081\u201390.","journal-title":"Ophthalmology"},{"key":"871_CR8","unstructured":"Glaucoma Summary Benchmarks - 2018 [Internet]. AAO; 2017 Nov p. 6. Available from: https:\/\/www.aao.org\/summary-benchmark-detail\/glaucoma-summary-benchmarks-2018"},{"key":"871_CR9","unstructured":"Glaucoma - Diagnosis and treatment - Mayo Clinic [Internet]. [cited 2019 Oct 15]. Available from: https:\/\/www.mayoclinic.org\/diseases-conditions\/glaucoma\/diagnosis-treatment\/drc-20372846"},{"key":"871_CR10","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1167\/iovs.16-20757","volume":"58","author":"GR Adelli","year":"2017","unstructured":"Adelli GR, Bhagav P, Taskar P, Hingorani T, Pettaway S, Gul W, et al. Development of a \u03949-tetrahydrocannabinol amino acid-dicarboxylate prodrug with improved ocular bioavailability. Invest Ophthalmol Vis Sci. 2017;58:2167\u201379.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"871_CR11","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/archopht.116.11.1433","volume":"116","author":"K Green","year":"1998","unstructured":"Green K. Marijuana smoking vs cannabinoids for glaucoma therapy. Arch Ophthalmol. 1998;116:1433\u20137.","journal-title":"Arch Ophthalmol"},{"key":"871_CR12","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/0024-3205(95)00194-B","volume":"56","author":"A Abrahamov","year":"1995","unstructured":"Abrahamov A, Abrahamov A, Mechoulam R. An efficient new cannabinoid antiemetic in pediatric oncology. Life Sci. 1995;56:2097\u2013102.","journal-title":"Life Sci"},{"key":"871_CR13","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/0002-9394(72)90741-6","volume":"74","author":"RS Hepler","year":"1972","unstructured":"Hepler RS, Frank IM, Ungerleider JT. Pupillary constriction after marijuana smoking. Am J Ophthalmol. 1972;74:1185\u201390.","journal-title":"Am J Ophthalmol"},{"key":"871_CR14","unstructured":"Marijuana and Medicine: Assessing the Science Base [Internet]. Washington, D.C.: National Academies Press; 1999 [cited 2020 Jan 23]. Available from: https:\/\/www.nap.edu\/catalog\/6376"},{"key":"871_CR15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S0161-6420(80)35258-5","volume":"87","author":"JC Merritt","year":"1980","unstructured":"Merritt JC, Crawford WJ, Alexander PC, Anduze AL, Gelbart SS. Effect of marihuana on intraocular and blood pressure in glaucoma. Ophthalmology. 1980;87:222\u20138.","journal-title":"Ophthalmology"},{"key":"871_CR16","first-page":"215","volume":"100","author":"AJ Flach","year":"2002","unstructured":"Flach AJ. Delta-9-tetrahydrocannabinol (THC) in the treatment of end-stage open-angle glaucoma. Trans Am Ophthalmol Soc. 2002;100:215\u201324.","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"15","key":"871_CR17","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1167\/iovs.18-24838","volume":"59","author":"S Miller","year":"2018","unstructured":"Miller S, Daily L, Leishman E, Bradshaw H, Straiker A. \u03949-Tetrahydrocannabinol and cannabidiol differentially regulate intraocular pressure. Invest Ophthalmol Vis Sci. 2018;59(15):5904\u201311.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"871_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0014-4835(77)90260-3","volume":"24","author":"K Green","year":"1977","unstructured":"Green K, Bigger JF, Kim K, Bowman K. Cannabinoid penetration and chronic effects in the eye. Exp Eye Res. 1977;24:197\u2013205.","journal-title":"Exp Eye Res"},{"key":"871_CR19","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/jps.22791","volume":"101","author":"T Hingorani","year":"2012","unstructured":"Hingorani T, Gul W, ElSohly M, Repka MA, Majumdar S. Effect of ion-pairing on in vitro transcorneal permeability of a \u03949-tetrahydrocannabinol prodrug: potential in glaucoma therapy. J Pharm Sci. 2012;101:616\u201326.","journal-title":"J Pharm Sci"},{"key":"871_CR20","unstructured":"Elsohly MA, Gul W, Repka MA, Majumdar S, inventors; ElSohly Laboratories Inc, assignee. Compositions containing delta-9-thc-amino acid esters and process of preparation. United States patent US 8,809,261. 2014 Aug 19."},{"issue":"3","key":"871_CR21","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1208\/s12249-008-9136-7","volume":"9","author":"S Thumma","year":"2008","unstructured":"Thumma S, Majumdar S, ElSohly MA, Gul W, Repka MA. Preformulation studies of a prodrug of \u0394 9-tetrahydrocannabinol. AAPS PharmSciTech Sep 1. 2008;9(3):982\u201390.","journal-title":"AAPS PharmSciTech Sep 1"},{"key":"871_CR22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/0039-6257(93)90141-S","volume":"37","author":"A Urtti","year":"1993","unstructured":"Urtti A, Salminen L. Minimizing systemic absorption of topically administered ophthalmic drugs. Surv Ophthalmol. 1993;37:435\u201356.","journal-title":"Surv Ophthalmol"},{"key":"871_CR23","doi-asserted-by":"crossref","unstructured":"Kale SN, Deore SL. Emulsion micro emulsion and nano emulsion: A Review. 2016.","DOI":"10.5530\/srp.2017.1.8"},{"key":"871_CR24","unstructured":"Sharma N, Bansal M, Visht S, Sharma P, Kulkarni G. Nanoemulsion: a new concept of delivery system. Chron Young Sci. 2010;5."},{"key":"871_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","volume":"2","author":"A Patel","year":"2013","unstructured":"Patel A, Cholkar K, Agrahari V, Mitra AK. Ocular drug delivery systems: an overview. World J Pharmacol. 2013;2:47\u201364.","journal-title":"World J Pharmacol"},{"key":"871_CR26","doi-asserted-by":"publisher","first-page":"001","DOI":"10.30574\/gscbps.2019.6.3.0030","volume":"6","author":"B Kumari","year":"2019","unstructured":"Kumari B. Ocular drug delivery system: approaches to improve ocular bioavailability. GSC Biol Pharm Sci. 2019;6:001\u201310.","journal-title":"GSC Biol Pharm Sci"},{"issue":"6","key":"871_CR27","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/pharmaceutics12060572","volume":"12","author":"A Youssef","year":"2020","unstructured":"Youssef A, Dudhipala N, Majumdar S. Ciprofloxacin loaded nanostructured lipid carriers incorporated into in-situ gels to improve management of bacterial endophthalmitis. Pharmaceutics Jun. 2020;12(6):572.","journal-title":"Pharmaceutics Jun"},{"issue":"3","key":"871_CR28","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1124\/jpet.119.256446","volume":"370","author":"KY Janga","year":"2019","unstructured":"Janga KY, Tatke A, Dudhipala N, Balguri SP, Ibrahim MM, Maria DN, Jablonski MM, Majumdar S. Gellan gum based sol-to-gel transforming system of natamycin transfersomes improves topical ocular delivery. J Pharmacol Exp Ther Sep 1. 2019;370(3):814\u201322.","journal-title":"J Pharmacol Exp Ther Sep 1"},{"key":"871_CR29","unstructured":"Inactive Ingredient Search for Approved Drug Products [Internet]. [cited 2020 Jan 28]. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/iig\/index.cfm?event=browseByLetter.page&Letter=P"},{"key":"871_CR30","doi-asserted-by":"crossref","unstructured":"Abisma\u0131\u0308l B, Canselier JP, Wilhelm AM, Delmas H, Gourdon C. Emulsification by ultrasound: drop size distribution and stability. Ultrason Sonochem. 1999;6:75\u201383.","DOI":"10.1016\/S1350-4177(98)00027-3"},{"key":"871_CR31","first-page":"1683","volume":"27","author":"T Delmas","year":"2011","unstructured":"Delmas T, Piraux H, Couffin A-C, Texier I, Vinet F, Poulin P, et al. How to prepare and stabilize very small nanoemulsions. Langmuir American Chemical Society. 2011;27:1683\u201392.","journal-title":"Langmuir American Chemical Society"},{"key":"871_CR32","doi-asserted-by":"publisher","first-page":"626","DOI":"10.4236\/jbnb.2011.225075","volume":"02","author":"C Lovelyn","year":"2011","unstructured":"Lovelyn C, Attama AA. Current state of nanoemulsions in drug delivery. J Biomater Nanobiotechnology. 2011;02:626\u201339.","journal-title":"J Biomater Nanobiotechnology"},{"issue":"1","key":"871_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/nano9010033","volume":"9","author":"A Tatke","year":"2019","unstructured":"Tatke A, Dudhipala N, Janga KY, Balguri SP, Avula B, Jablonski MM, Majumdar S. In situ gel of triamcinolone acetonide-loaded solid lipid nanoparticles for improved topical ocular delivery: tear kinetics and ocular disposition studies. Nanomaterials. 2019;9(1):33.","journal-title":"Nanomaterials"},{"key":"871_CR34","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.foodchem.2015.08.097","volume":"194","author":"Y Guan","year":"2016","unstructured":"Guan Y, Wu J, Zhong Q. Eugenol improves physical and chemical stabilities of nanoemulsions loaded with \u03b2-carotene. Food Chem. 2016;194:787\u201396.","journal-title":"Food Chem"},{"key":"871_CR35","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.preteyeres.2010.08.002","volume":"29","author":"Y Diebold","year":"2010","unstructured":"Diebold Y, Calonge M. Applications of nanoparticles in ophthalmology. Prog Retin Eye Res. 2010;29:596\u2013609.","journal-title":"Prog Retin Eye Res"},{"key":"871_CR36","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.2147\/IJN.S126199","volume":"12","author":"J Ban","year":"2017","unstructured":"Ban J, Zhang Y, Huang X, Deng G, Hou D, Chen Y, et al. Corneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasone. Int J Nanomedicine. 2017;12:1329\u201339.","journal-title":"Int J Nanomedicine"},{"key":"871_CR37","first-page":"71","volume":"49","author":"GD Chanana","year":"1995","unstructured":"Chanana GD, Sheth BB. Particle size reduction of emulsions by formulation design-II: effect of oil and surfactant concentration. PDA J Pharm Sci Technol. 1995;49:71\u20136.","journal-title":"PDA J Pharm Sci Technol"},{"key":"871_CR38","unstructured":"Pepi I, Lovri J, Filipovi J. Polymeric micelles in ocular drug delivery: rationale, strategies and challenges. :14."},{"key":"871_CR39","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.exer.2003.11.001","volume":"78","author":"JA Kiland","year":"2004","unstructured":"Kiland JA, Gabelt BT, Kaufman PL. Studies on the mechanism of action of timolol and on the effects of suppression and redirection of aqueous flow on outflow facility. Exp Eye Res. 2004;78:639\u201351.","journal-title":"Exp Eye Res"},{"key":"871_CR40","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.ophtha.2007.07.002","volume":"115","author":"KS Lim","year":"2008","unstructured":"Lim KS, Nau CB, O\u2019Byrne MM, Hodge DO, Toris CB, McLaren JW, et al. Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects: a crossover study. Ophthalmology. 2008;115:790\u20135.","journal-title":"Ophthalmology"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-020-00871-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-020-00871-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-020-00871-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T14:45:16Z","timestamp":1630939516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-020-00871-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,9]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["871"],"URL":"https:\/\/doi.org\/10.1007\/s13346-020-00871-9","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,9]]},"assertion":[{"value":"14 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All animal experiments conformed to the tenets of the Association for Research in Vision and Ophthalmology statement on the Use of Animals in Ophthalmic and Vision Research and followed the University of Mississippi Institutional Animal Care and Use Committee approved protocols (18-029).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"This research is sponsored by Emerald Bioscience, INC, and may lead to the development of products from which W.G., M.E., and S.M. may receive income as part of licensing fees and royalties paid to the University of Mississippi. M.E. is a scientific advisor to Emerald Bioscience. B.M. was the CMO of Emerald Bioscience, Inc. No competing financial interests exist for the other authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}